secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K/A
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001193125-23-212571
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 9.01, 2.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Carmell Corp files amended 8-K with historical unaudited financials of Legacy Carmell for H1 2023
--------------------------------------------------------------------------------

- Net loss of $7.1M for six months ended June 30, 2023; accumulated deficit reached $50.1M.
- Cash balance only $15,920 at June 30, 2023, with $14.7M current liabilities and $4.7M derivative liabilities.
- Business Combination closed July 14, 2023; shares commenced trading on Nasdaq July 17, 2023 under ticker CTCX.
- Pro forma unaudited condensed combined financials for FY 2022 and H1 2023 filed as Exhibit 99.3.
- Bryan Cassaday appointed Interim CFO; executive leadership includes Exec Chairman Rajiv Shukla and CEO Randolph Hubbell.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523212571/0001193125-23-212571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523212571/d496234d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-212571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer